Copyright Reports & Markets. All rights reserved.

Global Nicotine Addiction Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Nicotine Addiction Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Nicotine Addiction Treatment Market Size Growth Rate by Product
      • 1.4.2 OMS-527
      • 1.4.3 AT-1001
      • 1.4.4 CTDP-002
      • 1.4.5 EORA-101
      • 1.4.6 URB-694
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Nicotine Addiction Treatment Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Nicotine Addiction Treatment Market Size
      • 2.1.1 Global Nicotine Addiction Treatment Revenue 2014-2025
      • 2.1.2 Global Nicotine Addiction Treatment Sales 2014-2025
    • 2.2 Nicotine Addiction Treatment Growth Rate by Regions
      • 2.2.1 Global Nicotine Addiction Treatment Sales by Regions
      • 2.2.2 Global Nicotine Addiction Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Nicotine Addiction Treatment Sales by Manufacturers
      • 3.1.1 Nicotine Addiction Treatment Sales by Manufacturers
      • 3.1.2 Nicotine Addiction Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Nicotine Addiction Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nicotine Addiction Treatment Revenue by Manufacturers
      • 3.2.1 Nicotine Addiction Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nicotine Addiction Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Nicotine Addiction Treatment Price by Manufacturers
    • 3.4 Nicotine Addiction Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Nicotine Addiction Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Nicotine Addiction Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Nicotine Addiction Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Nicotine Addiction Treatment Sales by Product
    • 4.2 Global Nicotine Addiction Treatment Revenue by Product
    • 4.3 Nicotine Addiction Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Nicotine Addiction Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Nicotine Addiction Treatment by Countries
      • 6.1.1 North America Nicotine Addiction Treatment Sales by Countries
      • 6.1.2 North America Nicotine Addiction Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Nicotine Addiction Treatment by Product
    • 6.3 North America Nicotine Addiction Treatment by End User

    7 Europe

    • 7.1 Europe Nicotine Addiction Treatment by Countries
      • 7.1.1 Europe Nicotine Addiction Treatment Sales by Countries
      • 7.1.2 Europe Nicotine Addiction Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Nicotine Addiction Treatment by Product
    • 7.3 Europe Nicotine Addiction Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Nicotine Addiction Treatment by Countries
      • 8.1.1 Asia Pacific Nicotine Addiction Treatment Sales by Countries
      • 8.1.2 Asia Pacific Nicotine Addiction Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Nicotine Addiction Treatment by Product
    • 8.3 Asia Pacific Nicotine Addiction Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Nicotine Addiction Treatment by Countries
      • 9.1.1 Central & South America Nicotine Addiction Treatment Sales by Countries
      • 9.1.2 Central & South America Nicotine Addiction Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Nicotine Addiction Treatment by Product
    • 9.3 Central & South America Nicotine Addiction Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Nicotine Addiction Treatment by Countries
      • 10.1.1 Middle East and Africa Nicotine Addiction Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Nicotine Addiction Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Nicotine Addiction Treatment by Product
    • 10.3 Middle East and Africa Nicotine Addiction Treatment by End User

    11 Company Profiles

    • 11.1 Addex Therapeutics Ltd
      • 11.1.1 Addex Therapeutics Ltd Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Addex Therapeutics Ltd Nicotine Addiction Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Addex Therapeutics Ltd Nicotine Addiction Treatment Products Offered
      • 11.1.5 Addex Therapeutics Ltd Recent Development
    • 11.2 Astraea Therapeutics, LLC
      • 11.2.1 Astraea Therapeutics, LLC Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Astraea Therapeutics, LLC Nicotine Addiction Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Astraea Therapeutics, LLC Nicotine Addiction Treatment Products Offered
      • 11.2.5 Astraea Therapeutics, LLC Recent Development
    • 11.3 Cerecor Inc.
      • 11.3.1 Cerecor Inc. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Cerecor Inc. Nicotine Addiction Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Cerecor Inc. Nicotine Addiction Treatment Products Offered
      • 11.3.5 Cerecor Inc. Recent Development
    • 11.4 Embera NeuroTherapeutics, Inc.
      • 11.4.1 Embera NeuroTherapeutics, Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Embera NeuroTherapeutics, Inc. Nicotine Addiction Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Embera NeuroTherapeutics, Inc. Nicotine Addiction Treatment Products Offered
      • 11.4.5 Embera NeuroTherapeutics, Inc. Recent Development
    • 11.5 Hager Biosciences, LLC
      • 11.5.1 Hager Biosciences, LLC Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Hager Biosciences, LLC Nicotine Addiction Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Hager Biosciences, LLC Nicotine Addiction Treatment Products Offered
      • 11.5.5 Hager Biosciences, LLC Recent Development
    • 11.6 Heptares Therapeutics Limited
      • 11.6.1 Heptares Therapeutics Limited Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Heptares Therapeutics Limited Nicotine Addiction Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Heptares Therapeutics Limited Nicotine Addiction Treatment Products Offered
      • 11.6.5 Heptares Therapeutics Limited Recent Development
    • 11.7 Omeros Corporation
      • 11.7.1 Omeros Corporation Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Omeros Corporation Nicotine Addiction Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Omeros Corporation Nicotine Addiction Treatment Products Offered
      • 11.7.5 Omeros Corporation Recent Development
    • 11.8 RTI International
      • 11.8.1 RTI International Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 RTI International Nicotine Addiction Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 RTI International Nicotine Addiction Treatment Products Offered
      • 11.8.5 RTI International Recent Development

    12 Future Forecast

    • 12.1 Nicotine Addiction Treatment Market Forecast by Regions
      • 12.1.1 Global Nicotine Addiction Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Nicotine Addiction Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Nicotine Addiction Treatment Market Forecast by Product
      • 12.2.1 Global Nicotine Addiction Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Nicotine Addiction Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Nicotine Addiction Treatment Market Forecast by End User
    • 12.4 North America Nicotine Addiction Treatment Forecast
    • 12.5 Europe Nicotine Addiction Treatment Forecast
    • 12.6 Asia Pacific Nicotine Addiction Treatment Forecast
    • 12.7 Central & South America Nicotine Addiction Treatment Forecast
    • 12.8 Middle East and Africa Nicotine Addiction Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Nicotine Addiction Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Nicotine Addiction Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nicotine Addiction Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Nicotine Addiction Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nicotine Addiction Treatment in these regions.
      This research report categorizes the global Nicotine Addiction Treatment market by top players/brands, region, type and end user. This report also studies the global Nicotine Addiction Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Addex Therapeutics Ltd
      Astraea Therapeutics, LLC
      Cerecor Inc.
      Embera NeuroTherapeutics, Inc.
      Hager Biosciences, LLC
      Heptares Therapeutics Limited
      Omeros Corporation
      RTI International

      Market size by Product
      OMS-527
      AT-1001
      CTDP-002
      EORA-101
      URB-694
      Others
      Market size by End User
      Clinic
      Hospital
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Nicotine Addiction Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Nicotine Addiction Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Nicotine Addiction Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Nicotine Addiction Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Nicotine Addiction Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nicotine Addiction Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now